Bombay Leprosy Project

Pfizer India supports the cost of treatment of leprosy patients. These patients are administered medication by the Bombay Leprosy Project (BLP).

"BLP is one of the centres recognised by the government of India to receive and treat leprosy patients with Thalidomide. We are immensely grateful to Pfizer for this gesture of sponsoring the treatment of patients," said Padmashree Dr. R. Ganapati, an eminent Leprologist and Director of the Bombay Leprosy Project.

About Bombay Leprosy Project (BLP)

BLP is a registered non-profit voluntary organization working for the welfare of leprosy patients, in the city of Mumbai, since 1976. BLP has been engaged in Urban Leprosy Control Work for over two decades and has pioneered several cost effective simple strategies to improve the quality of life of Leprosy patients.

Pfizer Global    SITEMAP | CONTACT US   
Copyright © 2009 Pfizer Limited, India. All rights reserved. Bookmark this page | Feedback | Privacy Policy | Terms of Use
The product information provided in this site is intended only for residents of India. The products discussed herein may have different product labeling in different countries.
Site best viewed in Internet Explorer 5.5 + & Netscape Navigator 7.0 + with screen resolution of 1024 x 768 pixels.